Publications

Stern DF. 2008. ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer. J Mammary Gland Biol Neoplasia. 13:215-23.

DiGiovanna MP, Stern DF, Edgerton S, Broadwater G, Dressler LG, Budman DR, Henderson IC, Norton L, Liu ET, Muss HB, Berry DA, Hayes DF, Thor AD. 2008. Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B. J. Clin Oncol 26:2364-72

Zito CI, Riches D, Kolmakova J, Simons J, Egholm M, Stern DF. 2008. Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer. Genes chromosomes Cancer 47:633-8

Jia-Lin Ma N, Stern DF. 2008. Regulation of the Rad53 protein kinase in signal amplification by oligomer assembly and disassembly.  Cell Cycle 7: 808-17

Ma, J.L., Lee, S.J.,Duong, J.K., Stern, D.F. 2006 Activation of the Checkpoint Kinase Rad53 by the Phosphatidyl Inositol Kinase-like Kinase Mec1.J Biol Chem. 281(7):3954-63.

A.J. Jackson-Fisher, G. Bellinger, E.  Shum, J.K. Duong, A.S. Perkins, M. Gassmann, W. Muller, K. Lloyd, and D.F. Stern. 2006. Formation of Neu/ErbB2-induced  mammary tumors is unaffected by loss of ErbB4. Oncogene 5:5664-72

*DiGiovanna, M.P. * Stern, D.F., Edgerton,  S., Whalen, S.G., Moore II, D., and A.D. Thor. 2005. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
Journal of Clinical Oncology23:1152-60. *authors contributed equally to this work

Tsvetkov, L., and D.F. Stern. 2005. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Cell Cycle 4:166-171.

Li, Jia., and D.F. Stern. 2005. Regulation of Chk2 by DNA-dependent protein kinase. J. Biol. Chem. 280:12041-50.

Tsvetkov, L., and D.F. Stern. 2005. Interaction of Chromatin-Associated Plk 1 and Mcm7. J. Biol. Chem. 280:11943-7.

Tsvetkov, L., Tsekova, R., Xu., X., and D.F.Stern. 2005. The Plk1 Polo Box domain mediates a cell cycle- and DNA damage-regulated interaction with Chk2. Cell Cycle. 4:609-617.

Amin, D., Tuck, D., and D.F. Stern. 2005. Neuregulin-regulated gene expression in mammary carcinoma cells. Experimental Cell Research 309:12-23.

D.F. Stern. Phosphoproteomics for Oncology Discovery and Treatment. 2005. Expert Opin Ther Targets. 9:851-60.

Li, Jia., and D.F. Stern. 2005. DNA Damage Regulates Chk2 Association with Chromatin. J.Biol.Chem.280:3748-56